Enterovirus 71 vaccine clinical trials
How each study uses enterovirus 71 vaccine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the enterovirus 71 vaccine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- EV71 vaccine
- 12
Studies by the year they started
12 studies that test it; most in 2011 (3)
| Year | Studies |
|---|---|
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 9 · Other 3
Sinovac Biotech Co., Ltd (8) · Enimmune Corporation (1) · Jiangsu Province Centers for Disease Control and Prevention (1) · National Health Research Institutes, Taiwan (1) · Institute of Medical Biology, Chinese Academy of Medical Sciences (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test enterovirus 71 vaccine.
- Jan 2027Bridging Clinical Trial of EV71 Vaccine in Vietnamese ChildrenNot applicable · Sinovac Biotech Co., Ltd
Studies
Open first, then newest update. How each study uses enterovirus 71 vaccine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 12
- Bridging Clinical Trial of EV71 Vaccine in Vietnamese ChildrenNot yet recruitingNot applicableSinovac Biotech Co., LtdNCT07793175Written as EV71 vaccineHow we know
- Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 VaccineRecruitingPhase 4Institute of Medical Biology, Chinese Academy of Medical SciencesNCT06146088Written as EV71 VaccineHow we know
- A Study to Evaluate the Efficacy, Immunogenicity and Safety of an EV71 Vaccine in Healthy Infants and ChildrenCompletedPhase 3Enimmune CorporationNCT05099029Written as EV71 vaccineHow we know
- Clinical Trial for Batch Consistency of EV71 VaccineCompletedPhase 4Sinovac Biotech Co., LtdNCT07026500Written as EV71 VaccineHow we know
- Safety and Immunogenicity of EV71 Vaccine With or Without Aluminum Adjuvant in InfantsWithdrawnPhase 2Sinovac Biotech Co., LtdNCT01812135Written as 400 U EV71 vaccine with adjuvantHow we know
- Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy ChildrenCompletedPhase 1Sinovac Biotech Co., LtdNCT01273246Written as 100U inactivated Enterovirus Type 71 VaccineHow we know
- Efficacy Evaluation for Inactivated Vaccine (Vero Cell) Against EV71CompletedPhase 4Jiangsu Province Centers for Disease Control and PreventionNCT03582761Written as EV71 vaccineHow we know
- Phase IV Clinical Trial, Immunogenicity and Safety of EV71 VaccineCompletedPhase 4Sinovac Biotech Co., LtdNCT03278132Written as EV71 vaccineHow we know
- A Study to Evaluate the Safety and Immunogenicity of EV71 VaccineCompletedPhase 1National Health Research Institutes, TaiwanNCT01268787Written as EV71 vaccineHow we know
- An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) VaccineCompletedPhase 3Sinovac Biotech Co., LtdNCT01507857Written as 400U /0.5ml EV71 vaccineHow we know
- Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy AdultsCompletedPhase 1Sinovac Biotech Co., LtdNCT01273233Written as Inactivated Enterovirus Type 71 VaccineHow we know
- Safety and Immunogenicity of an Inactivated EV71 Vaccine in InfantsCompletedPhase 2Sinovac Biotech Co., LtdNCT01421121Written as 100U EV71 vaccine with adjuvantHow we know
As the comparator · 2 — what is tested is compared with enterovirus 71 vaccine
- Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza VaccineCompletedPhase 4China National Biotec Group Company LimitedNCT04091880Written as EV71 vaccineHow we know
- The Phase IVd of Inactivated Enterovirus 71 VaccineStatus unknownPhase 4Chinese Academy of Medical SciencesNCT03296410Written as EV71 vaccineHow we know